Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of crisaborole in Japanese patients with atopic dermatitis
NCT04498403Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Sep 2020
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
A Phase 3 trial of AN2728 ointment vehicle in atopic dermatitis (AD), sponsored by Pfizer. Started Sep 2020; status: terminated.
02
Drugs
AN2728 ointment vehicle
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04498403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04498403.